1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cystic Fibrosis Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Cystic Fibrosis Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Cystic Fibrosis Drugs Market Share by Application: 2021-2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Cystic Fibrosis Drugs Market
1.8.1 Global Cystic Fibrosis Drugs Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Cystic Fibrosis Drugs Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Cystic Fibrosis Drugs Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Cystic Fibrosis Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Cystic Fibrosis Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Cystic Fibrosis Drugs Sales Volume Market Share by Region (2015-2020)
3.2 Global Cystic Fibrosis Drugs Sales Revenue Market Share by Region (2015-2020)
3.3 North America Cystic Fibrosis Drugs Sales Volume
3.3.1 North America Cystic Fibrosis Drugs Sales Volume Growth Rate (2015-2020)
3.3.2 North America Cystic Fibrosis Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Cystic Fibrosis Drugs Sales Volume
3.4.1 East Asia Cystic Fibrosis Drugs Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Cystic Fibrosis Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Cystic Fibrosis Drugs Sales Volume (2015-2020)
3.5.1 Europe Cystic Fibrosis Drugs Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Cystic Fibrosis Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Cystic Fibrosis Drugs Sales Volume (2015-2020)
3.6.1 South Asia Cystic Fibrosis Drugs Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Cystic Fibrosis Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Cystic Fibrosis Drugs Sales Volume (2015-2020)
3.7.1 Southeast Asia Cystic Fibrosis Drugs Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Cystic Fibrosis Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Cystic Fibrosis Drugs Sales Volume (2015-2020)
3.8.1 Middle East Cystic Fibrosis Drugs Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Cystic Fibrosis Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Cystic Fibrosis Drugs Sales Volume (2015-2020)
3.9.1 Africa Cystic Fibrosis Drugs Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Cystic Fibrosis Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Cystic Fibrosis Drugs Sales Volume (2015-2020)
3.10.1 Oceania Cystic Fibrosis Drugs Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Cystic Fibrosis Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Cystic Fibrosis Drugs Sales Volume (2015-2020)
3.11.1 South America Cystic Fibrosis Drugs Sales Volume Growth Rate (2015-2020)
3.11.2 South America Cystic Fibrosis Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Cystic Fibrosis Drugs Sales Volume (2015-2020)
3.12.1 Rest of the World Cystic Fibrosis Drugs Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Cystic Fibrosis Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Cystic Fibrosis Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Cystic Fibrosis Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Cystic Fibrosis Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Cystic Fibrosis Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Cystic Fibrosis Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Cystic Fibrosis Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Cystic Fibrosis Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Cystic Fibrosis Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Cystic Fibrosis Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Cystic Fibrosis Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Cystic Fibrosis Drugs Sales Volume Market Share by Type (2015-2020)
14.2 Global Cystic Fibrosis Drugs Sales Revenue Market Share by Type (2015-2020)
14.3 Global Cystic Fibrosis Drugs Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Cystic Fibrosis Drugs Consumption Volume by Application (2015-2020)
15.2 Global Cystic Fibrosis Drugs Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Cystic Fibrosis Drugs Business
16.1 Actavis
16.1.1 Actavis Company Profile
16.1.2 Actavis Cystic Fibrosis Drugs Product Specification
16.1.3 Actavis Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Arcturus Therapeutics
16.2.1 Arcturus Therapeutics Company Profile
16.2.2 Arcturus Therapeutics Cystic Fibrosis Drugs Product Specification
16.2.3 Arcturus Therapeutics Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Novartis
16.3.1 Novartis Company Profile
16.3.2 Novartis Cystic Fibrosis Drugs Product Specification
16.3.3 Novartis Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 F. Hoffmann-La Roche
16.4.1 F. Hoffmann-La Roche Company Profile
16.4.2 F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Specification
16.4.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Anthera Pharmaceuticals
16.5.1 Anthera Pharmaceuticals Company Profile
16.5.2 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Specification
16.5.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Gilead Sciences
16.6.1 Gilead Sciences Company Profile
16.6.2 Gilead Sciences Cystic Fibrosis Drugs Product Specification
16.6.3 Gilead Sciences Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Chiesi Farmaceutici
16.7.1 Chiesi Farmaceutici Company Profile
16.7.2 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Specification
16.7.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Abbott
16.8.1 Abbott Company Profile
16.8.2 Abbott Cystic Fibrosis Drugs Product Specification
16.8.3 Abbott Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Vertex Pharmaceuticals
16.9.1 Vertex Pharmaceuticals Company Profile
16.9.2 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Specification
16.9.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Boehringer Ingelheim
16.10.1 Boehringer Ingelheim Company Profile
16.10.2 Boehringer Ingelheim Cystic Fibrosis Drugs Product Specification
16.10.3 Boehringer Ingelheim Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Merck Sharp & Dohme
16.11.1 Merck Sharp & Dohme Company Profile
16.11.2 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Specification
16.11.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 PharmaSwiss
16.12.1 PharmaSwiss Company Profile
16.12.2 PharmaSwiss Cystic Fibrosis Drugs Product Specification
16.12.3 PharmaSwiss Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Corbus Pharmaceuticals
16.13.1 Corbus Pharmaceuticals Company Profile
16.13.2 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Specification
16.13.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Proteostasis Therapeutics
16.14.1 Proteostasis Therapeutics Company Profile
16.14.2 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Specification
16.14.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Neovii Biotech
16.15.1 Neovii Biotech Company Profile
16.15.2 Neovii Biotech Cystic Fibrosis Drugs Product Specification
16.15.3 Neovii Biotech Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Johnson & Johnson
16.16.1 Johnson & Johnson Company Profile
16.16.2 Johnson & Johnson Cystic Fibrosis Drugs Product Specification
16.16.3 Johnson & Johnson Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 Genzyme
16.17.1 Genzyme Company Profile
16.17.2 Genzyme Cystic Fibrosis Drugs Product Specification
16.17.3 Genzyme Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Pharmaxis
16.18.1 Pharmaxis Company Profile
16.18.2 Pharmaxis Cystic Fibrosis Drugs Product Specification
16.18.3 Pharmaxis Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.19 Novo Nordisk
16.19.1 Novo Nordisk Company Profile
16.19.2 Novo Nordisk Cystic Fibrosis Drugs Product Specification
16.19.3 Novo Nordisk Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.20 Insmed
16.20.1 Insmed Company Profile
16.20.2 Insmed Cystic Fibrosis Drugs Product Specification
16.20.3 Insmed Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.21 PTC Therapeutics
16.21.1 PTC Therapeutics Company Profile
16.21.2 PTC Therapeutics Cystic Fibrosis Drugs Product Specification
16.21.3 PTC Therapeutics Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.22 United Medical
16.22.1 United Medical Company Profile
16.22.2 United Medical Cystic Fibrosis Drugs Product Specification
16.22.3 United Medical Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.23 Venus Remedies
16.23.1 Venus Remedies Company Profile
16.23.2 Venus Remedies Cystic Fibrosis Drugs Product Specification
16.23.3 Venus Remedies Cystic Fibrosis Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Cystic Fibrosis Drugs Manufacturing Cost Analysis
17.1 Cystic Fibrosis Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Cystic Fibrosis Drugs
17.4 Cystic Fibrosis Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Cystic Fibrosis Drugs Distributors List
18.3 Cystic Fibrosis Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Cystic Fibrosis Drugs (2021-2026)
20.2 Global Forecasted Revenue of Cystic Fibrosis Drugs (2021-2026)
20.3 Global Forecasted Price of Cystic Fibrosis Drugs (2015-2026)
20.4 Global Forecasted Production of Cystic Fibrosis Drugs by Region (2021-2026)
20.4.1 North America Cystic Fibrosis Drugs Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Cystic Fibrosis Drugs Production, Revenue Forecast (2021-2026)
20.4.3 Europe Cystic Fibrosis Drugs Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Cystic Fibrosis Drugs Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Cystic Fibrosis Drugs Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Cystic Fibrosis Drugs Production, Revenue Forecast (2021-2026)
20.4.7 Africa Cystic Fibrosis Drugs Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Cystic Fibrosis Drugs Production, Revenue Forecast (2021-2026)
20.4.9 South America Cystic Fibrosis Drugs Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Cystic Fibrosis Drugs Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Cystic Fibrosis Drugs by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Cystic Fibrosis Drugs by Country
21.2 East Asia Market Forecasted Consumption of Cystic Fibrosis Drugs by Country
21.3 Europe Market Forecasted Consumption of Cystic Fibrosis Drugs by Countriy
21.4 South Asia Forecasted Consumption of Cystic Fibrosis Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Cystic Fibrosis Drugs by Country
21.6 Middle East Forecasted Consumption of Cystic Fibrosis Drugs by Country
21.7 Africa Forecasted Consumption of Cystic Fibrosis Drugs by Country
21.8 Oceania Forecasted Consumption of Cystic Fibrosis Drugs by Country
21.9 South America Forecasted Consumption of Cystic Fibrosis Drugs by Country
21.10 Rest of the world Forecasted Consumption of Cystic Fibrosis Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer